| Name | Title | Contact Details |
|---|
Blue Matter Consulting is a management consulting firm dedicated to the life sciences industry, particularly in pharmaceuticals and biotechnology. Founded in 2012, the company has grown from a single office to a global presence with locations in the United States, Europe, and India. The leadership team, including managing partners Ashwin Dandekar, Emily Hua, and George Schmidt, guides the firms strategic growth. The firm offers a wide range of services to help life sciences companies maximize value. These services include new product planning, launch strategy and management, commercial strategy for existing products, market access strategy, corporate strategy, transaction support, and organizational design. Blue Matter also focuses on specific therapeutic areas such as oncology and rare diseases, providing tailored strategies and solutions. With a diverse client base of over 250 companies, including many top global biopharmaceutical firms, Blue Matter Consulting is recognized for its strategic expertise and personalized service in the life sciences sector.
Started with nothing more than a vision and an entrepreneurial spirit, AmeriLux International was formed in May 2004. AmeriLux is a value-adding distributor of multiwall and corrugated polycarbonate sheet products, PVC sheet and liner panels, and steel coil. Headquartered in De Pere, Wisconsin, AmeriLux sources and distributes materials from and to companies around the world. It is by building and maintaining strategic, win-win partnerships with vendors, customers, and employees that AmeriLux is able to profitably – and sustainably – grow its business. With an emphasis on customer service and support, AmeriLux International seeks to provide its customers with creative, cost-effective solutions to their unique challenges. This solutions-focused mentality has driven facility expansions and key equipment investments, enabling AmeriLux to provide a variety of fabrication services, component assembly, and turn-key manufacturing solutions. Strongly committed to educating the architectural, building, and construction communities on the benefits of using its products, AmeriLux International provides distance learning courses, webinars, and in-person presentations whereby continuing education units can be earned. These online educational programs are free, one-hour-long programs that focus on topics such as energy efficiency, polycarbonate glazing solutions, and sustainable design. This has led to a greater grass roots demand for their products. To reduce lead times and improve on-time delivery with key customers, AmeriLux International started AmeriLux Transportation — a trucking company with its own drivers and equipment — in June 2012. AmeriLux Transportation is a direct delivery carrier and regularly operates in the US. With the recent formation of AmeriLux Logistics, AmeriLux now has access to a network of qualified carriers and a wide range of freight shipping services - yet another offering to better serve the marketplace!
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Starr Insurance is a prominent part of Starr Companies, a global insurance and investment organization founded in 1919 by Cornelius Vander Starr. Initially established as the first American-owned insurance agency in Shanghai, the company has grown to operate across six continents, becoming a significant player in the insurance industry. Starr Insurance offers a diverse range of products and services, including commercial property and casualty insurance, as well as specialty coverages such as aviation, marine, energy, and excess casualty insurance. The company serves a wide array of clients, including leading businesses in sectors like construction, maritime, energy, and aerospace. With its extensive global presence, Starr Insurance is well-equipped to provide comprehensive insurance solutions tailored to the needs of businesses worldwide.